Delayed gastric emptying, Gastro-esophageal reflux disease, Non-ulcer dyspepsia.
Cinitapride acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors. It slows the actions of the muscles to reduce the symptoms of conditions such as acid reflux, ulcer dyspepsia, and delayed gastric emptying.
drowsiness, diarrhea., Angioedema, gynacomastia
and sleep disorders. Long term use may increase risk of hip, spine or wrist fractures in patients with osteoporosis or in those having medications that increase the risk of osteoporosis like corticosteroids ., abdominal pain and discomfort, skin rash, Nauea, vomiting, itching, constipation, diarrhea, dry mouth, sudden rashes on the body, bloating and gas